시장보고서
상품코드
1429528

세계의 측방유동면역분석(LFIA) 기반 신속 검사에 대한 시장 보고서(2024년)

Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2024

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 175 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

측방유동면역분석(LFIA) 기반 신속 검사 시장 규모는 향후 몇 년 동안 소폭 감소할 것으로 예상됩니다. 2028년에는 연평균 복합 성장률(CAGR) -1.6%로 77억 9,000만 달러 규모로 성장할 것으로 예상됩니다. 예측 기간 동안 예상되는 성장은 의료 접근성 증가, COVID-19 전염병의 영향, 고령화 인구 증가, 가정용 측면 유동성 분석 장비에 대한 수요 증가, 접근성 향상, 규제 당국의 승인 증가로 인해 발생할 것으로 예상됩니다. 예측 기간 동안 주목할 만한 동향으로는 다중 또는 반복적인 LFIA 기반 신속 검사 및 결과 저장/통신을 위한 기술 발전이 있습니다. 또한, 신제품 또는 개선된 제품을 도입하기 위한 파트너십 및 협업의 형성, 환자가 집에서 자가 관리 및 건강 관리를 할 수 있는 재택 검사 키트 개발, 질병 검진을 위한 인공지능 기반 검사에 대한 투자에 초점을 맞추고 있습니다. 그리고 환자들이 저렴한 가격으로 접근할 수 있도록 저비용 검사 키트를 만드는 것이 필수적입니다.

측방유동면역분석(LFIA) 기반 신속 검사 시장은 재택 의료 환경에서의 현장 검사에 대한 수요로 인해 성장할 것으로 예상됩니다. 현장 진단 및 치료에 있어 현장 검사는 필수적이며, LFIA는 신속성, 정확성, 간편성, 비용 효율성으로 인해 널리 사용되고 있습니다. 최근 COVID-19 사태는 Acro Biotech COVID-19 Rapid POC CE-IVD와 라텍스 강화 측방유동면역분석(LFIA)을 채택한 OZO의 변형 제품에서 볼 수 있듯이 신속한 스크리닝 및 모니터링을 위한 LFIA 기기의 중요성을 강조하고 있습니다. 위한 LFIA 디바이스의 중요성을 강조하고 있습니다. 19번의 테스트. 이에 따라 재택 의료 현장의 현장 검사에 대한 필요성으로 인해 시장이 성장할 것으로 예상됩니다.

측방유동면역분석(LFIA) 기반 신속 검사 시장은 만성 질환의 유병률 증가로 인해 성장할 것으로 예상됩니다. 이러한 장기적인 건강 상태는 조기 발견, 현장 검사 및 정기적인 모니터링이 필요하며, LFIA 기반 신속 검사는 빠른 결과를 제공하여 만성 질환 관리에 도움을 줄 수 있습니다. 세계보건기구(WHO)는 매년 비감염성 질환(NCD)으로 인한 사망자 수가 상당하다고 보고하고 있으며, 심혈관 질환, 암, 만성 호흡기 질환, 당뇨병과 같은 질병에 대처하는 데 있어 LFIA의 역할을 강조하고 있습니다. 따라서 시장은 만성 질환의 발생률 증가로 인해 자극을 받고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 거시경제 시나리오

  • 고인플레이션이 시장에 미치는 영향
  • 우크라이나·러시아 전쟁이 시장에 미치는 영향
  • COVID-19에 의한 시장에 대한 영향

제5장 세계 시장 규모와 성장

  • 세계의 시장 성장 촉진요인과 억제요인
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
  • 세계의 시장 규모 실적과 성장, 2018-2023년
  • 세계의 시장 규모 예측과 성장, 2023-2028년, 2033년

제6장 시장 세분화

  • 세계의 측방유동면역분석(LFIA) 기반 신속 검사 시장, 기술별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 경쟁 어세이
  • 샌드위치 어세이
  • 다중 검출 어세이
  • 세계의 측방유동면역분석(LFIA) 기반 신속 검사 시장, 용도별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 감염증
  • 임신과 생식력
  • 독물학
  • 기타 용도
  • 세계의 측방유동면역분석(LFIA) 기반 신속 검사 시장, 최종사용자별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 병원과 클리닉
  • 진단 검사실
  • 재택 케어
  • 기타 최종사용자

제7장 지역 및 국가 분석

  • 세계의 측방유동면역분석(LFIA) 기반 신속 검사 시장, 지역별, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 세계의 측방유동면역분석(LFIA) 기반 신속 검사 시장, 국가별, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 상황과 기업 개요

  • 측방유동면역분석(LFIA) 기반 신속 검사 시장 경쟁 상황
  • 측방유동면역분석(LFIA) 기반 신속 검사 시장 기업 개요
    • Abbott Laboratories
    • F. Hoffmann-La Roche
    • Quidel Corporation
    • Becton, Dickinson and Company
    • Danaher Corporation

제31장 기타 주요 및 혁신적인 기업

  • Siemens AG
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer Inc.
  • Hologic, Inc.
  • LTEK Co., Ltd.
  • JOYSBIO Biotechnology
  • Jiangsu Medomics Medical Technologies
  • Diagnocure
  • Ubio Biotechnology Systems
  • Elabscience(R) Immunoassay Kits
  • FyoniBio/Glycotope GmbH
  • Atomo Diagnostics Limited
  • INDICAL Bioscience
  • Lionex Gmbh

제32장 경쟁 벤치마킹

제33장 경쟁 대시보드

제34장 주요 인수합병

제35장 향후 전망과 가능성 분석

제36장 부록

ksm 24.03.21

The rapid test based on Lateral Flow Immunoassay (LFIA) is a straightforward technology-driven diagnostic device employed for detecting the presence of specific targets, such as pathogens or biomarkers, in samples obtained from the human body. These samples encompass various bodily fluids such as urine, saliva, blood, and sweat.

The primary techniques include the competitive assay, sandwich assay, and multiplex detection assay. The competitive assay specifically determines the presence of targets, such as pathogens or biomarkers, within the collected samples. Its applications span infectious diseases, pregnancy and fertility assessments, toxicology, and others, making it applicable in diverse settings such as hospitals, clinics, diagnostic laboratories, home care, and more.

The lateral flow immunoassay (LFIA) based rapid test market research report is one of a series of new reports from The Business Research Company that provides lateral flow immunoassay (LFIA) based rapid test market statistics, including lateral flow immunoassay (LFIA) based rapid test industry global market size, regional shares, competitors with a lateral flow immunoassay (LFIA) based rapid test market share, detailed lateral flow immunoassay (LFIA) based rapid test market segments, market trends and opportunities, and any further data you may need to thrive in the lateral flow immunoassay (LFIA) based rapid test industry. This lateral flow immunoassay (LFIA) based rapid test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The lateral flow immunoassay (lfia) based rapid test market size has declined steeply in recent years. It will grow from ' $9.19 billion in 2023 to $8.33 billion in 2024 at a compound annual growth rate (CAGR) of -9.4%. The growth observed in the historical period can be ascribed to several factors, including a surge in infectious disease cases, heightened demand for point-of-care testing within home care settings, augmented healthcare expenditure, and the expansion of emerging markets.

The lateral flow immunoassay (lfia) based rapid test market size is expected to see marginal decline in the next few years. It will grow to $7.79 billion in 2028 at a compound annual growth rate (CAGR) of -1.6%. The growth anticipated in the forecast period can be attributed to several factors, including increased healthcare access, the impact of the COVID-19 pandemic, a rising aging population, a growing demand for home-based lateral flow assay devices, enhanced accessibility, and an upswing in regulatory approvals. Noteworthy trends in the forecast period involve the advancement of technologies for multiple or repetitive LFIA-based rapid tests and the storage/communication of results. There is also a focus on forming partnerships and collaborations to introduce new or improved products, the development of at-home test kits for patients to self-administer and manage their health in their own homes, investments in artificial intelligence-based tests for disease screening and detection, and the imperative to create low-cost test kits to ensure affordable access for patients.

The lateral flow immunoassay (LFIA) based rapid test market is anticipated to witness growth driven by the demand for point-of-care testing in home care settings. Point-of-care testing is crucial for swift on-site diagnosis and treatment, with LFIA being widely used due to its speed, precision, simplicity, and cost-effectiveness. The recent COVID-19 outbreak has underscored the significance of LFIA devices for rapid screening and surveillance, as seen with products such as Acro Biotech COVID-19 Rapid POC CE-IVD and OZO's variations employing Latex Enhanced Lateral Flow Immunoassays (LFIAs) for COVID-19 testing. Consequently, the market is expected to thrive due to the need for point-of-care testing in home care settings.

The lateral flow immunoassay (LFIA) based rapid test market is set to experience growth fueled by the increasing prevalence of chronic diseases. These long-term health conditions demand early detection, point-of-care testing, and regular monitoring, with LFIA-based rapid tests offering prompt results and aiding in the management of chronic diseases. The World Health Organization reports a significant number of deaths attributed to non-communicable diseases (NCDs) annually, emphasizing the role of LFIA in addressing conditions such as cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes. The market is thus stimulated by the rising incidence of chronic diseases.

Leading companies in the lateral flow immunoassay (LFIA) based rapid test market are concentrating on innovative products to enhance their market share. Notable among these is Abbott Laboratories, which introduced the Panbio COVID-19 antigen self-test, designed for individuals to self-detect the SARS-CoV-2 virus causing COVID-19. The self-test employs Abbott's lateral flow technology, providing quick results within 15 minutes using a minimally invasive nose swab. To streamline the process, Abbott's NAVICA mobile app facilitates self-registration, result interpretation, and reporting in accordance with ICMR requirements.

The focus on healthcare investments by various stakeholders is intensifying, contributing to the lateral flow immunoassay (LFIA) based rapid test market. Such investments support research and development efforts aimed at improving LFIA test sensitivity, specificity, and overall performance. This includes the development of new LFIA assays, identification of novel biomarkers, and enhancements in detection methods. In Australia, the government has substantially increased hospital funding, reaching an estimated $32.7 billion in 2025-26, showcasing a commitment to healthcare investments.

In August 2023, Danaher Corporation acquired Abcam plc for $5.7 billion, aligning with Danaher's strategy to bolster its life sciences business. The acquisition of Abcam, a UK-based biotechnology company specializing in LFIA-based rapid tests, is expected to enhance value for shareholders and deliver outstanding results for both the workforce and clients.

Major companies operating in the lateral flow immunoassay (lfia) based rapid test market report are Abbott Laboratories, F. Hoffmann-La Roche, Quidel Corporation, Becton, Dickinson and Company, Danaher Corporation, Siemens AG, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., PerkinElmer Inc., Hologic, Inc., LTEK Co., Ltd., JOYSBIO Biotechnology, Jiangsu Medomics Medical Technologies, Diagnocure, Ubio Biotechnology Systems, Elabscience® Immunoassay Kits, FyoniBio / Glycotope GmbH, Atomo Diagnostics Limited, INDICAL Bioscience, Lionex Gmbh, BIOMED Labordiagnostik GmbH, Charles River Laboratories, EKF Diagnostics, Launch Diagnostics, Diagnostic Instruments Ltd., Qiagen N.V., Merck KGaA, XPhyto Therapeutics, 3a Diagnostics, Roche Holding AG, BATM, Biomaxima, SensDx, Vitrosens Biotechnology, Bioeasy Biotechnology, Fujirebio, Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc., CTK Biotech, Wamadiagnostica, Marksans Pharma Ltd., Lana Al Khaleej, Natejah Medical Supplies, Synlab, K2 Medical's, SA Biomedical Group

North America was the largest region in the lateral flow immunoassay (LFIA) based rapid test market in 2023. Asia-Pacific was the second largest region in the global lateral flow immunoassay (LFIA) based rapid test market. The regions covered in the lateral flow immunoassay (lfia) based rapid test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the lateral flow immunoassay (lfia) based rapid test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

Lateral Flow Immunoassay (LFIA) based rapid test market consists of sales of conjugate pads, nitrocellulose membrane and absorbent pad. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lateral flow immunoassay (lfia) based rapid test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lateral flow immunoassay (lfia) based rapid test? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The lateral flow immunoassay (lfia) based rapid test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Technique: Competitive Assay; Sandwich Assay; Multiplex Detection Assay
  • 2) By Application: Infectious Disease; Pregnancy And Fertility; Toxicology; Cardiac Marker And Cholesterol Testing; Other Applications
  • 3) By End-Users: Hospitals And Clinics; Diagnostic Laboratories; Home Care; Other End Users
  • Companies Mentioned: Abbott Laboratories; F. Hoffmann-La Roche; Quidel Corporation; Becton, Dickinson and Company; Danaher Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Characteristics

3. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Trends And Strategies

4. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Size and Growth

  • 5.1. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Segmentation

  • 6.1. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Competitive Assay
  • Sandwich Assay
  • Multiplex Detection Assay
  • 6.2. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Infectious Disease
  • Pregnancy & Fertility
  • Toxicology
  • Other Applications
  • 6.3. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital & Clinic
  • Diagnostic Laboratory
  • Home Care
  • Other End Users

7. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Regional And Country Analysis

  • 7.1. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 8.1. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 9.1. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 9.2. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 10.1. India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 11.1. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 11.2. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 12.1. Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 13.1. Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 14.1. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 14.2. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 15.1. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 15.2. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 16.1. UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 17.1. Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 18.1. France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 19.1. Italy Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 20.1. Spain Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 21.1. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 21.2. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 22.1. Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 23.1. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 23.2. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 24.1. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 24.2. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 25.1. Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 25.2. Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 26.1. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 26.2. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 27.1. Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 28.1. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 28.2. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 29.1. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • 29.2. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Competitive Landscape And Company Profiles

  • 30.1. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Competitive Landscape
  • 30.2. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Company Profiles
    • 30.2.1. Abbott Laboratories
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. F. Hoffmann-La Roche
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Quidel Corporation
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Becton, Dickinson and Company
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Danaher Corporation
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Other Major And Innovative Companies

  • 31.1. Siemens AG
  • 31.2. Thermo Fisher Scientific Inc.
  • 31.3. Bio-Rad Laboratories, Inc.
  • 31.4. PerkinElmer Inc.
  • 31.5. Hologic, Inc.
  • 31.6. LTEK Co., Ltd.
  • 31.7. JOYSBIO Biotechnology
  • 31.8. Jiangsu Medomics Medical Technologies
  • 31.9. Diagnocure
  • 31.10. Ubio Biotechnology Systems
  • 31.11. Elabscience® Immunoassay Kits
  • 31.12. FyoniBio / Glycotope GmbH
  • 31.13. Atomo Diagnostics Limited
  • 31.14. INDICAL Bioscience
  • 31.15. Lionex Gmbh

32. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Competitive Benchmarking

33. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

35. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Future Outlook and Potential Analysis

  • 35.1 Lateral Flow Immunoassay (LFIA) Based Rapid Test Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Lateral Flow Immunoassay (LFIA) Based Rapid Test Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Lateral Flow Immunoassay (LFIA) Based Rapid Test Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제